Drug Type Blood components, Enzyme |
Synonyms 凝血酶冻干粉, 凝血酶原(牛血或猪血), 凝血酶散 |
Target |
Action inhibitors |
Mechanism Fibrinogen inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date China (11 Dec 2020), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hemorrhage | China | 11 Dec 2020 |